Letters Guidance on collaboration with drug industry An alternative set of principles for consideration BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2927 (Published 24 April 2012) Cite this as: BMJ 2012;344:e2927 Article Related content Metrics Responses Peer review Related articles Paper Pharmaceutical industry sponsorship and research outcome and quality: systematic review Published: 29 May 2003; BMJ 326 doi:10.1136/bmj.326.7400.1167 Research Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study Published: 11 October 2011; BMJ 343 doi:10.1136/bmj.d5621 Views & Reviews Guidelines for collaboration with industry should be transparent Published: 09 October 2013; BMJ 347 doi:10.1136/bmj.f6100 See more Constitutional symptoms in a young person BMJ December 07, 2016, 355 i5781; DOI: https://doi.org/10.1136/bmj.i5781 What it feels like to be an interesting teaching opportunity BMJ December 07, 2016, 355 i6190; DOI: https://doi.org/10.1136/bmj.i6190 Author’s reply to Dangoor and colleagues BMJ December 05, 2016, 355 i6508; DOI: https://doi.org/10.1136/bmj.i6508 Time for guidelines on safety netting? BMJ December 05, 2016, 355 i6411; DOI: https://doi.org/10.1136/bmj.i6411 The BMJ Christmas appeal 2016-7: Orbis, the sight savers BMJ December 01, 2016, 355 i6425; DOI: https://doi.org/10.1136/bmj.i6425 Cited by... Guidelines for collaboration with industry should be transparentFulltext PDF Towards greater transparency in the life sciencesFulltext PDF
